The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Prognostic value of mature MicroRNA-21 and MicroRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR
Open accessAbstract
Background: microRNA (miRNA) expression profiles are being intensively investigated for their involvement in carcinogenesis. We evaluated the prognostic value of mature microRNA-21 (miR-21) and mature microRNA-205 (miR-205) overexpression in non–small cell lung cancer (NSCLC). Patients and methods: We studied 48 pairs of NSCLC fresh frozen tissue specimens collected at time of surgery and before chemotherapy. Highly specific amplification and quantification of mature miR-21 and mature miR-205 was achieved using looped real time RT-PCR. Results: miRNA expression, determined by real time RT-PCR, was defined by ΔΔCt measurements. We detected overexpression of mature miR-21 in 25 (52.0%) of the 48 NSCLC paired specimens and overexpression of miR-205 in 31 (64.6%). Overexpression was assessed after comparison of miRNA expression in NSCLC tissues and in their corresponding noncancerous tissues with respect to U6 expression. During the follow-up period, 29 of 48 (60.4%) patients relapsed, and 23 of 48 died (47.9%). Mature miR-21 was upregulated in 16 of 29 (55.2%) patients who relapsed and 15 of 23 (65.2%) patients who died. Mature miR-205 was overexpressed in 19 of 29 patients who relapsed (65.5%) and 15 of 23 patients who died (65.2%). Mature miR-21 overexpression correlated with overall survival (OS) of the patients (P = 0.027), whereas overexpression of mature miR-205 did not. Conclusions: Our results suggest that overexpression of mature miR-21 is an independent negative prognostic factor for OS in NSCLC patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Recently, miR-21 expression levels have proven useful prognostic markers in non-small cell lung cancer (Markou et al., 2008; Yanaihara et al., 2006).”
From Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21 (2010) · cites this paper as Markou et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
MicroRNA expression profiles classify human cancers
Lü, J., Getz, G. A., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,637
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
Real-time quantification of microRNAs by stem-loop RT-PCR
Chen, C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni178 · Cited by 4,989
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., & Johnson, J. M. (2005) · Nature · doi:10.1038/nature03315 · Cited by 4,755
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,096
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053
Flagged first, then by citations
Research works printed but not linked: 1
- 2006, Mol Vis, 12, 1175
Cited by
Sorted by citations
Items 301–400 of 440
Prognostic Role of MicroRNA-21 in Non-small Cell Lung Cancer: a Meta-analysis
Ma, X., Liu, L., Liu, X., Li, Y., Deng, L., Xiao, Z., Liu, Y., Shi, H., & Wei, Y.-Q. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.5.2329 · Cited by 22
Zhang, J., Zhang, Y., Shen, W., Fu, R., Ding, Z., Zhen, Y., & Yu, W. C. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109058 · Cited by 22
Wang, J., Li, S., Xu, J., Lu, Y., Lin, M., Wang, C., Zhang, C., Lin, G., & Jia, L. (2020) · Chemical Communications · doi:10.1039/c9cc08289a · Cited by 22
miRNA in Molecular Diagnostics
Matulić, M., Gršković, P., Petrović, A., Begić, V., Harabajsa, S., & Korać, P. (2022) · Bioengineering · doi:10.3390/bioengineering9090459 · Cited by 24
Alotaibi, A. G., Li, J. V., & Gooderham, N. J. (2023) · Cancers · doi:10.3390/cancers15030627 · Cited by 21
Weighted Network-Based Inference of Human MicroRNA-Disease Associations
Jiang, Q., Hao, Y., Wang, G., Zhang, T., & Wang, Y. (2010) · International Conference on Frontier of Computer Science and Technology (FCST) · doi:10.1109/fcst.2010.18 · Cited by 21
Stromal Expression of MicroRNA-21 in Advanced Colorectal Cancer Patients with Distant Metastases
Lee, K. S., Nam, S. K., Koh, J., Kim, D., Kang, S., Choe, G., Kim, W. H., & Lee, H. S. (2016) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2016.03.19 · Cited by 22
Machine learning identifies 10 feature miRNAs for lung squamous cell carcinoma
Zheng, Y., Sun, B., & Xiao, Z. (2020) · Gene · doi:10.1016/j.gene.2020.144669 · Cited by 21
Wang, Y., Shi, J., Wu, Y., Xu, W., Wang, Q., Zhang, J., Jiang, M., & Gu, G. (2012) · Tumori Journal · doi:10.1177/030089161209800618 · Cited by 20
Use of MicroRNAs in Personalized Medicine
Avcı, Ç. B., & Baran, Y. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-748-8_19 · Cited by 20
The ambiguous role of microRNA-205 and its clinical potential in pancreatic ductal adenocarcinoma
Träger, M. M., Rehkämper, J., Ullerich, H., Steinestel, K., Wardelmann, E., Senninger, N. J., & Dhayat, S. A. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2755-9 · Cited by 19
Distinctive microRNA expression signatures in proton-irradiated mice
Khan, S. Y., Tariq, M., Perrott, J. P., Brumbaugh, C. D., Kim, H. J., Shabbir, M. I., Ramesh, G. T., & Pourmand, N. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1738-z · Cited by 18
Molecular simulation studies of 3,3′-Diindolylmethane as a Potent MicroRNA-21 Antagonist
Hosen, S. M. Z., Junaid, M., Dash, R., Islam, N., Chowdhury, J., Alam, M. J., Nath, S., Shakil, M. S., Azam, A., & Quader, S. (2017) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_266_16 · Cited by 18
Function of miR-200a in proliferation and apoptosis of non-small cell lung cancer cells
Huang, Y., Bao, T., Li, Z., Ji, G., & Zhang, L. (2020) · Oncology Letters · doi:10.3892/ol.2020.11649 · Cited by 17
Ye, Q., Putila, J. J., Raese, R. A., Dong, C., Qian, Y. R., Dowlati, A., & Guo, N. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147658 · Cited by 17
Integration of MicroRNAs with nanomedicine: tumor targeting and therapeutic approaches
Telkoparan‐Akillilar, P., Chichiarelli, S., Tucci, P., & Saso, L. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1569101 · Cited by 19
Broeck, A. V. D., Ozenne, P., Eymin, B., & Gazzéri, S. (2010) · Cell Adhesion & Migration · doi:10.4161/cam.4.1.10885 · Cited by 17
Ionizing Radiation-inducible microRNA-21 Induces Angiogenesis by Directly Targeting PTEN
Zhang, Y., Chen, Z., Feng, L., Jiang, P., Li, X., & Wang, X. (2019) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2019.20.5.1587 · Cited by 17
Yu, D., Ma, Y., & Yu, Z. (2019) · Scientific Reports · doi:10.1038/s41598-019-39226-x · Cited by 16
Alterations of MicroRNAs in Solid Cancers and Their Prognostic Value
Chira, P., Vareli, K., Sainis, I., Papandreou, C. N., & Briasoulis, E. C. (2010) · Cancers · doi:10.3390/cancers2021328 · Cited by 16
Marin, I., Ofek, E., Bar, J., Prisant, N., Perelman, M., Avivi, C., Lavy-Shahaf, G., Onn, A., Katz, R. L., & Barshack, I. (2020) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2019-206420 · Cited by 16
Oil-Encapsulated Nanodroplet Array for Bio-molecular Detection
Qiao, W., Zhang, T., Yen, T., Ku, T., Song, J., Lian, I., & Lo, Y. (2014) · Annals of Biomedical Engineering · doi:10.1007/s10439-014-1039-z · Cited by 15
Computational prediction of human disease-related microRNAs by path-based random walk
Mugunga, I., Ju, Y., Liu, X., & Huang, X. J. (2017) · Oncotarget · doi:10.18632/oncotarget.17226 · Cited by 15
Identifying human microRNA–disease associations by a new diffusion-based method
Liao, B., Ding, S., Chen, H., Li, Z., & Cai, L. (2015) · Journal of Bioinformatics and Computational Biology · doi:10.1142/s0219720015500146 · Cited by 14
Liu, X., Song, B., Li, S., Wang, N., & Yang, H. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6705 · Cited by 14
Kaina, B., Izzotti, A., Xu, J., Christmann, M., Pulliero, A., Zhao, X., Dobreanu, M., & Au, W. W. (2018) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2018.07.003 · Cited by 14
Wei, J., He, S., Mao, Y., Wu, L., Liu, X., Effah, C. Y., Guo, H., & Wu, Y. (2021) · Microchimica Acta · doi:10.1007/s00604-021-05051-1 · Cited by 14
MicroRNAs modulation in lung cancer: exploring dual mechanisms and clinical prospects
HUSSAIN, S., Bokhari, H., Fan, X., MALIK, S. I., Ijaz, S., Shereen, M. A., & Fatima, A. (2024) · Biocell · doi:10.32604/biocell.2024.044801 · Cited by 13
Zhong, X., Deng, Y., Chen, G., & Yang, H. (2018) · Oncology Letters · doi:10.3892/ol.2018.9627 · Cited by 13
Ding, S., Zheng, Y., Xu, Y., Zhao, X., & Zhong, C. (2019) · Europe PMC (PubMed Central) · Cited by 13
Aamri, M. E., Mohammadi, H., & Amine, A. (2023) · Microchimica Acta · doi:10.1007/s00604-023-06087-1 · Cited by 13
Haigl, B., Vanas, V., Setinek, U., Hegedűs, B., Gsur, A., & Sutterlüty, H. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2272 · Cited by 13
Prognostic role of microRNA-205 in multiple human malignant neoplasms: a meta-analysis of 17 studies
Zhang, J., Sun, M., Song, N., Deng, Z., Xue, C., & Yang, J. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-006244 · Cited by 13
Minárovits, J., & Niller, H. H. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3345-3 · Cited by 13
Maftouh, M., Avan, A., Galvani, E., Peters, G. J., & Giovannetti, E. (2013) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2013007191 · Cited by 12
Yan, H. H., Zhang, Q., Cheng, R., Fu, Z., Liu, J. J., Gao, P. F., Zou, H. Y., Liang, G., Huang, C. Z., & Wang, J. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c00029 · Cited by 12
Recent Advances in Microfluidics for Nucleic Acid Analysis of Small Extracellular Vesicles in Cancer
Zhand, S., Goss, D. M., Cheng, Y. Y., & Warkiani, M. E. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401295 · Cited by 12
Altered Expression of PTEN and Its Major Regulator MicroRNA-21 in Pulmonary Neuroendocrine Tumors
Lee, H. W., Ha, S. Y., & Roh, M. S. (2014) · Journal of Pathology and Translational Medicine · doi:10.4132/koreanjpathol.2014.48.1.17 · Cited by 11
Diagnostic and prognostic accuracy of miR-21 in renal cell carcinoma: a systematic review protocol
Rasti, A., Mehrazma, M., Madjd, Z., Keshtkar, A., Roudi, R., & Babashah, S. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-009667 · Cited by 11
MicroRNAs: Key Regulators in Lung Cancer
Founini, Y. E., Chaoui, I., Dehbi, H., Mzibri, M. E., Abounader, R., & Guessous, F. (2021) · MicroRNA · doi:10.2174/2211536610666210527102522 · Cited by 11
Sensitive and homogeneous microRNA detection using branched cascade enzymatic amplification
Chi, B., Liang, R., Zhang, L., & Qiu, J. (2015) · Chemical Communications · doi:10.1039/c5cc02864g · Cited by 11
TUMIR: an experimentally supported database of microRNA deregulation in various cancers
Dong, L., Luo, M., Wang, F., Zhang, J., Li, T., & Yu, J. (2013) · Journal of Clinical Bioinformatics · doi:10.1186/2043-9113-3-7 · Cited by 11
Cui, F., Qiu, Q., Peng, G., Li, X., Liu, X., & Chen, X. (2019) · Analytical Methods · doi:10.1039/c9ay00783k · Cited by 11
mikroRNA jako cel terapeutyczny w chorobach nowotworowych
Alwani, A., & Baj‐Krzyworzeka, M. (2021) · Postępy Biochemii · doi:10.18388/pb.2021_390 · Cited by 11
Circulating RNA: looking at the liver through a frosted glass
Falcón‐Pérez, J. M., & Royo, F. (2015) · Biomarkers · doi:10.3109/1354750x.2015.1101785 · Cited by 10
Kim, M., Kim, D., & Kim, D.-E. (2020) · The Analyst · doi:10.1039/d0an01329c · Cited by 10
Upregulation of microRNA-205 is a potential biomarker for intracranial aneurysms
Zhong, Z., Wu, J., Yuan, K., Song, Z., Ma, Z., Zhong, Y., Fang, X., & Zhang, W. (2019) · Neuroreport · doi:10.1097/wnr.0000000000001279 · Cited by 9
MicroRNA signatures as clinical biomarkers in lung cancer
Lianidou, E. S., Markou, A., & Zavridou, M. (2015) · Current Biomarker Findings · doi:10.2147/cbf.s55358 · Cited by 9
Self-citationSystems medicine in colorectal cancer: from a mathematical model toward a new type of clinical trial
Castagnino, N., Maffei, M., Tortolina, L., Zoppoli, G. M., Piras, D., Nencioni, A., Morán, E., Ballestrero, A., Patrone, F., & Parodi, S. (2016) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1342 · Cited by 8
Expression of microRNAs-106b in nonsmall cell lung cancer
Li, Y., Tian, J., Guo, Z.-J., Zhang, Z. D., Xiao, C., & Wang, X. (2018) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.235344 · Cited by 9
Lu, S., Chen, L., & Tang, L. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28741 · Cited by 9
MicroRNA‑98‑5p regulates the proliferation and apoptosis of A549�cells by targeting MAP4K3
Wang, Z., Han, Z., Zhang, L., Zhang, S., & Wang, B. (2019) · Oncology Letters · doi:10.3892/ol.2019.10771 · Cited by 8
Song, N. (2016) · Pakistan Journal of Pharmaceutical Sciences · doi:10.36721/pjps/29/2(sup)/02.03.2016/367/679-684 · Cited by 8
Findlay (2010) · The Open Cancer Journal · doi:10.2174/1874079001003010055 · Cited by 8
Cheng, Y. (2012) · InTech eBooks · doi:10.5772/1337 · Cited by 9
Findlay, V. J. (2010) · The Open Cancer Journal · Cited by 7
The Impact of Pre-analytical Factors on the Reliability of miRNA Measurements
Markou, A. N., & Lianidou, E. S. (2019) · Current Pathobiology Reports · doi:10.1007/s40139-019-00191-9 · Cited by 7
Self-citationIs miR therapeutic targeting still a miRage?
Levantini, E. (2021) · Frontiers in Bioscience-Landmark · doi:10.52586/4979 · Cited by 7
Aberrant Epigenetic Regulation in Breast Cancer
Toland, A. E. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3345-3_5 · Cited by 7
Linking common non-coding RNAs of human lung cancer and M. tuberculosis
Barh, D., Tiwari, S., Kumavath, R., Ghosh, P., & Azevedo, V. (2018) · Bioinformation · doi:10.6026/97320630014337 · Cited by 7
Kawano, S., Araki, K., Bai, J., Furukawa, I., Tateishi, K., Yoshinobu, K., Usuki, S., Nimmo, R. A., Kaname, T., Yoshihara, M., et al. (2023) · Cancer Science · doi:10.1111/cas.15794 · Cited by 6
Aamri, M. E., Mohammadi, H., & Amine, A. (2024) · Sensors & Diagnostics · doi:10.1039/d4sd00187g · Cited by 6
Wang, X., Zhang, Y., & Zhi, X. (2017) · Thoracic Cancer · doi:10.1111/1759-7714.12480 · Cited by 6
Xu, J., Li, Z., Li, Y., Lu, Y., & Wang, J. (2021) · Chemical Communications · doi:10.1039/d1cc01150b · Cited by 6
MiR-30a-5p hampers proliferation of lung squamous cell carcinoma through targeting FBXO45.
Zeng, F., You, S., & Dai, X. (2022) · PubMed · doi:10.14670/hh-18-424 · Cited by 6
Role of microRNAs in solid tumors
Hamano, R., Ishii, H., Miyata, H., Doki, Y., & Mori, M. (2011) · Journal of Nucleic Acids Investigation · doi:10.4081/jnai.2011.2164 · Cited by 6
LOMDA: Linear optimization for miRNA-disease association predictionPreprint
Lee, Y.-L., Pech, R., Po, M., Hao, D., & Zhou, T. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/751651 · Cited by 6
The role of microRNAs in breast cancer: Diagnostic and therapeutic implications
Ghanbari, M., Karari, K., Altalebi, S. A. R., Majeed, S. A., & Haghi, M. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.146386 · Cited by 7
Dynamical network analysis reveals key microRNAs in progressive stages of lung cancer
Kong, C., Yao, Y., Bing, Z., Guo, B., Huang, L., Huang, Z., & Lai, Y. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007793 · Cited by 5
WWC1, a target of miR-138-5p, facilitates the progression of prostate cancer
Liu, M., Liu, S., & Chen, F. (2022) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2022.08.001 · Cited by 5
Prognostic role of TPL2 in early-stage non-small cell lung cancer
Boldrini, L., Giordano, M., Servadio, A., Niccoli, C., Bertoglio, P., Lucchi, M., Melfi, F. M. A., Mussi, A., & Fontanini, G. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6430 · Cited by 5
The value of microRNA-21 as a biomarker for the prognosis of lung cancer
Zhang, W. Y., Wei, L., Luo, R., Liu, H., & Chen, J. (2020) · Medicine · doi:10.1097/md.0000000000021483 · Cited by 5
Wang, H., Zuo, Z., Ren, L., Yuan, R., Li, Q., Ding, S., & Luo, R. (2016) · Journal of Electroanalytical Chemistry · doi:10.1016/j.jelechem.2016.10.045 · Cited by 5
Absolute Quantification of Selected microRNAs Expression in Endometrial Cancer by Digital PCR
Bogaczyk, A., Potocka, N., Paszek, S., Skrzypa, M., Zuchowska, A., Kośny, M., Kluz-Barłowska, M., Zawlik, I., & Kluz, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063286 · Cited by 4
Dietary regulation of miRNA in precision medicine of lung cancer
Mondal, P., & Meeran, S. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823008-4.00002-0 · Cited by 4
Current and Future Developments in Cancer Therapy Research: miRNAs as New Promising Targets or Tools
Iorio, M. V., Casalini, P., Piovan, C., Braccioli, L., & Tagliabue, E. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-615-9_19 · Cited by 4
The Role of microRNAs in Cancer
Leva, G. D., & Croce, C. M. (2015) · Wiley eBooks · doi:10.1002/9781118468678.ch8 · Cited by 6
Bao, G., Sun, J. S., Zheng, H., Hou, J., Huang, J., Wei, J., Fu, Y., Qiu, J., Zou, X., Xiang, B., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.747305 · Cited by 3
Mohammadi, P., Forouzesh, F., & Kouhkan, F. (2024) · Iranian Journal of Public Health · doi:10.18502/ijph.v53i5.15598 · Cited by 3
Relationships Between Icariin and Anti-Apoptotic miRNA-21 in Mouse Blastocyst Development In vitro
Shi, Y., Zhan-he, W. A. N. G., Cao, Y., Yan, L., Tian, J.-L., ZHANG, C., Jia, Z.-Y., Wu, C., & Gao, J. (2013) · Journal of Integrative Agriculture · doi:10.1016/s2095-3119(13)60284-1 · Cited by 3
Bhaumik, S., Ahmad, F., & Das, B. R. (2017) · Applied cancer research/Applied Cancer Research · doi:10.1186/s41241-017-0034-8 · Cited by 3
Prognostic and Predictive Biomarkers for Colorectal Cancer
Manne, U., Putcha, B. K., Samuel, T., & Srivastava, S. (2017) · Wiley eBooks · doi:10.1002/9781118468869.ch13 · Cited by 3
MicroRNA-205 Promotes Cell Proliferation of Non-Small Cell Lung Cancer by Targeting Smad4
Zeng, Y., & Zhu, J. (2015) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000328 · Cited by 2
TLR9 agonist enhances lung cancer invasiveness by alternating miRNA expression profile
Ren, T., He, X., Cai, Y.-Y., & Wang, Y. (2011) · Scientific Research and Essays · doi:10.5897/sre11.332 · Cited by 2
MicroRNAs in Cancer (An Overview)
Ferracin, M., Călin, G. A., & Negrini, M. (2010) · Springer eBooks · doi:10.1007/978-94-007-0298-1_1 · Cited by 2
The Role of MicroRNA in Lung Cancer Drug Resistance and Targeted Therapy
Gong, Z., Dong, Z., Yang, L., Yang, J., Li, J., Le, Y., Wang, S., Ye, M., & Lin, H. (2014) · Springer eBooks · doi:10.1007/978-3-319-05134-5_3 · Cited by 2
[Effect of PI3K/AKT pathway on cisplatin resistance in non-small cell lung cancer].
Zhang, Y., Lu, H., & Xu, G. (2014) · Europe PMC (PubMed Central) · doi:10.3779/j.issn.1009-3419.2014.08.09 · Cited by 2
Prognostic Role of miR-205 in Early-Stage (T1N0) Non-Small Cell Lung Cancer
Boldrini, L., Giordano, M., Servadio, A., Alì, G., Cocco, A., Lucchi, M., Bertoglio, P., Melfi, F. M. A., Mussi, A., & Fontanini, G. (2014) · Advances in Lung Cancer · doi:10.4236/alc.2014.32007 · Cited by 2
Detection, Profiling, and Quantification of miRNA Expression
Wang, Z., & Yang, B. (2009) · Springer eBooks · doi:10.1007/978-3-642-04928-6_1 · Cited by 2
MicroRNAs as biomarkers for the diagnosis and prognosis of human cancer
Asslaber, D., Hofbauer, J. P., Greil, R., & Egle, A. (2010) · Journal of Nucleic Acids Investigation · doi:10.4081/jnai.2010.2130 · Cited by 2
Lin, L., Zhang, Y., Wei, Q., Lin, H., Li, X., Yu, M.-E., Wang, J., Huang, Z., & Xue, D. (2021) · Talanta · doi:10.1016/j.talanta.2021.123037 · Cited by 2
Zhou, X., Zhou, Q., Zhou, D., Li, F., Zhang, C., & Yang, Y. (2022) · Translational Cancer Research · doi:10.21037/tcr-21-2438 · Cited by 2
Progress in the effect of microRNA-21 on diseases via autophagy.
Zeng, Z., Cai, J., Liao, Y., Sun, S., & Xie, L. (2022) · PubMed Central · doi:10.11817/j.issn.1672-7347.2022.210647 · Cited by 2
P53 and microRNAs in chronic lymphocytic leukemia
Bloehdorn, J., Langer, C., Döhner, H., Zenz, T., & Stilgenbauer, S. (2011) · Journal of Nucleic Acids Investigation · doi:10.4081/jnai.2011.e8 · Cited by 2
Characterizing the endoribonuclease activity of APE1.
Kim, W. C. (2010) · doi:10.24124/2010/bpgub633 · Cited by 2
Reference Gene: In-Species Universality Versus Between-Species Uniquity
Xu, W. (2025) · Springer eBooks · doi:10.1007/978-981-96-9603-1_7 · Cited by 1
Circulating microRNAs in preterm white matter injury: a systems biology/qPCR-based pilot study
Ibanibo, L. A., Montañez, R., Ortega-Leon, A., Lubián-Gutiérrez, M., Benavente‐Fernández, I., & Lubián-López, S. (2026) · Pediatric Research · doi:10.1038/s41390-026-04854-3 · Cited by 1
Genomic Pathology of Lung Cancer
Craddock, K. J., Tam, S., Zhu, C., & Tsao, M. (2012) · Springer eBooks · doi:10.1007/978-94-007-5842-1_1 · Cited by 1
P53 and microRNAs in chronic lymphocytic leukemia
Bloehdorn, J., Langer, C., Döhner, H., Zenz, T., & Stilgenbauer, S. (2011) · Journal of Nucleic Acids Investigation · doi:10.4081/jnai.2011.2414 · Cited by 1
Bover, I., Rolfo, C. D., Lewintre, E. J., Sirera, R., Camps, C., CHAIB-OUKADOUR, I., Ramírez, J. L., Benlloch, S., Molina‐Vila, M. Á., Simonetti, S., et al. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.04.016 · Cited by 1
Metadata
- Authors
- Markou, A., Tsaroucha, E. G., Kaklamanis, L., Fotinou, M., Georgoulias, V., & Lianidou, E. S.
- Affiliations
- National and Kapodistrian University of Athens (GR)
- Sotiria General Hospital (GR)
- Onassis Cardiac Surgery Center (GR)
- University of Crete (GR)
- Corresponding author
- Lianidou, Evi S
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-10-01
- Volume
- 54
- Issue
- 10
- Pages
- 1696-1704
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2154551754
- Cited by
- 441
- References
- 39
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 6 · 2023: 9 · 2022: 14 · 2021: 16 · 2020: 21 · 2019: 21 · 2018: 18 · 2017: 31 · 2016: 26 · 2015: 34 · 2014: 42 · 2013: 33 · 2012: 51
- FWCI
- 12.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Clinical Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National and Kapodistrian University of Athens
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Health Sciences › Medicine › Oncology › Lung Cancer Research Studies
- Keywords
- miR-21, microRNA-205, non-small cell lung cancer, prognostic factors, microRNA overexpression, overall survival, tumor recurrence, microRNA quantification
- MeSH terms
- Carcinoma, Non-Small-Cell Lung, Humans, Lung Neoplasms, Prognosis, Multivariate Analysis, Survival Analysis, Reverse Transcriptase Polymerase Chain Reaction, MicroRNAs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review